Versant Ventures VI GP-GP, LLC

CIK 1777652 · last filed 2022-05-03

Versant Ventures VI GP-GP, LLC is a corporate insider who has filed 8 SEC Form 4 insider transactions across 6 companies since 2020. The most recent filing, for TPST, was dated May 3, 2022. Across all open-market trades the lifetime net is +$13.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $222.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$222.89M

Companies

6

Total Filings

8

Lifetime Open-Market Net

$13.72M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
TPST	10%+ Owner	154,664	$0.89	$137.0K	$0	1	2022-05-03
IPSC	10%+ Owner	13,080,909	$2.02	$26.49M	$0	1	2022-02-02
Oyster Point Pharma, Inc. (OYST) Delisted	10%+ Owner	2,236,888	$11.17	$24.99M	$0	2	2021-12-23
GLUE	10%+ Owner	8,897,053	$22.06	$196.27M	$18.00M	1	2021-06-30
Repare Therapeutics Inc. (RPTX) Delisted	10%+ Owner	0	$2.65	$0	$0	2	2021-06-03
Akero Therapeutics, Inc. (AKRO) Delisted	10%+ Owner	3,309,616	$54.65	$180.87M	-$4.28M	1	2020-01-06

Recent Filings

8 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-05-03	TPST	—	—	$0	EDGAR
2022-02-02	IPSC	Other (J)	−1,073,976	$0	EDGAR
2021-12-23	Oyster Point Pharma, Inc. (OYST) Delisted	Other (J)	−1,813,266	$0	EDGAR
2021-06-30	GLUE	Mixed	+51,682,842	$18.00M	EDGAR
2021-06-03	Repare Therapeutics Inc. (RPTX) Delisted	Other (J)	−750,000	$0	EDGAR
2021-03-30	Oyster Point Pharma, Inc. (OYST) Delisted	Other (J)	−2,901,222	$0	EDGAR
2020-12-17	Repare Therapeutics Inc. (RPTX) Delisted	Other (J)	−3,250,000	$0	EDGAR
2020-01-06	Akero Therapeutics, Inc. (AKRO) Delisted	Mixed	−2,269,761	-$4.28M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.